biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Perhaps the greatest piece of investment wisdom ever...

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Nov 10, 2023 8:16pm

89 Views

Post# 35729711

RE:Perhaps the greatest piece of investment wisdom ever...

I think it's time to advertise TheTruth1234's buddy, TailwindsRsrch, again.

Let's see how big we can make it, this time.

Dan, with friends like TheTruth1234, you can go a long ways in a direction you might not like.

It's going to be bigger and more fun this time.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario